BROADCASTS.com

As an expert in mast cell activation syndrome (MCAS), Dr Tania Dempsey, imparts priceless information regarding the nature and treatment of this insidious condition. Among many insights, Dr Dempsey explains how to distinguish histamine intolerance from MCAS, the impact of this condition on gastrointestinal health, as well as views on the connection between COVID-19 and MCAS. Importantly, Dr Dempsey draws on years of experience to provide advice on the identification and management of MCAS.

Dr. Dempsey is Board Certified in Internal Medicine and a Diplomate of the American Board of Integrative and Holistic Medicine. She has served as an attending physician at a large multi-specialty medical practice in White Plains, NY, and since opened AIM Centre for Personalised Medicine.

*Highlights *

\n
• What is MCAS and how prevalent is it? (6:30)
\n
• Examining the connection between gut health and MCAS (13:00)
\n
• Histamine intolerance versus MCAS (21:30)
\n
• Why a personalised diet is important (27:00)
\n
• MCAS and COVID-19 (38:20)
\n
• How to spot MCAS (47:20)
\n
• Stabilising mast cells and avoiding triggers (53:00)
\n

**Useful links and resources:

Follow Metagenics on Instagram here -
\nhttps://www.instagram.com/metagenics_anz/

Or on Facebook - https://www.facebook.com/metagenics

Website: https://www.drtaniadempsey.com/
\nLinkedIn: AIM Centre for Personalised Medicine - https://www.linkedin.com/company/armonk-integrative-medicine#:~:text=Tania%20Tyles%20Dempsey%2C%20MD%2C%20founder,Dr.
\nTwitter account: https://twitter.com/drtaniadempsey?lang=en

Paper Tania mentions: Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327-332. doi:10.1016/j.ijid.2020.09.016

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529115/